How Bio-Techne (TECH) Makes Money: A Visual Guide
Bio-Techne (TECH) generated $1.22B in revenue (TTM through Q4 2025), earning $81.10M in net profit (6.7% margin). Its largest revenue source is Consumables (88.2% of revenue). Below is an interactive breakdown of how revenue flows through the income statement.
Bio-Techne (TECH) Income Statement Flow
Frequently asked questions
How does Bio-Techne (TECH) make money?
- Bio-Techne (TECH) primarily makes money through Consumables, which accounts for 88.2% of total revenue. For TTM through Q4 2025, Bio-Techne generated $1.22B in total revenue with a net profit margin of 6.7%.
What is Bio-Techne (TECH) gross profit margin?
- Bio-Techne (TECH) reported a gross profit margin of 65.2% for TTM through Q4 2025, equivalent to $792.76M in gross profit. This means Bio-Techne retains 65.2% of each revenue unit after direct costs of production.
What is Bio-Techne (TECH) operating profit margin?
- Bio-Techne (TECH) reported an operating profit margin of 9.6% for TTM through Q4 2025, equivalent to $116.97M in operating profit. This reflects profitability after operating expenses such as R&D, sales, and administration, but before taxes and non-operating items.
What is Bio-Techne (TECH) net profit margin?
- Bio-Techne (TECH) reported a net profit margin of 6.7% for TTM through Q4 2025, equivalent to $81.10M in net profit. This is the share of revenue that remains as profit after all expenses, taxes, and non-operating items.
How much does Bio-Techne (TECH) invest in R&D?
- Bio-Techne (TECH) invested $97.98M in research and development in TTM through Q4 2025 (8.1% of total revenue). R&D spending reflects investment in future products, services, and technologies.
How much does Bio-Techne (TECH) spend on capital expenditures?
- Bio-Techne (TECH) spent $26.30M on capital expenditures in TTM through Q4 2025 (2.2% of total revenue). Capital expenditures represent investments in physical assets such as property, equipment, and infrastructure.
What is Bio-Techne (TECH) free cash flow?
- Bio-Techne (TECH) generated $223.02M in free cash flow for TTM through Q4 2025 (18.3% of total revenue). Free cash flow is the cash remaining after capital expenditures and represents the company's ability to fund growth, pay dividends, or reduce debt.
What is Bio-Techne (TECH) effective tax rate?
- Bio-Techne (TECH) had an effective tax rate of 29% for TTM through Q4 2025. This is the actual percentage of pre-tax income paid as income taxes.
About this data
- What is a Sankey diagram?
- A Sankey diagram shows how money flows through a company from revenue to net profit. The width of each flow represents its proportion.
- How is the data calculated?
- We use the income statement from company filings. For TTM (Trailing Twelve Months), we sum the last four quarters. Revenue flows to cost of revenue and gross profit, then to operating expenses (R&D, S&M, G&A) and operating profit.
- When was this data last updated?
- Based on company filings through TTM through Q4 2025.